Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model
Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass
Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modelling
Course of thrombin activation markers in patients implanted with Palmaz—Scnatz stents: first experiences with a post-interventional anticoagulation regimen
The effect of recombinant aprotinin on t-PA-induced bleeding in rats
Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis
Changes in clot deformability— a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction
Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation
The coagulopathy of heat stroke: alterations in coagulation and fibrinolysis in heat stroke patients during the pilgrimage (Haj) to Makkah
Modulation of protein C inhibitor activity
Characterization of adhesion of non-exogenously stimulated and resting platelets in normal plasma to fibrinogen and its fragments
Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix
Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement
Fibrinogen present in EDTA— anticoagulated plasma stimulates the tissue-type plasminogen activatorcatalysed conversion of plasminogen to plasmin
Anticoagulant and antiprotease activities of aprosulate sodium, a new synthetic polyanion, in human plasma and purified systems
Basal plasma concentration of tissue plasminogen activator (t-PA) and the adaption to strenuous exercise in familial hypercholesterolaemia (FH)
Is the coagulopathy of hepatosplenic schistosomiasis immune-related?
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin™). An experimental investigation in healthy volunteers
British Society for Haemostasis and Thrombosis : King's College London 12 September 1994
Measurement of tissue factor pathway inhibitor in normal and post-heparin plasma
Homozygous factor V-deficient patients show resistance to activated protein C whereas heterozygotes do not
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers
Acquired factor VII deficiency associated with pleural liposarcoma
A data management program for the Electra 800 automatic analyser
Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site
Plasma thrombomodulin levels increase with the severity of the diabetic retinopathy
High stability of dilute human α-thrombin in salt solutions
How to calculate the maximum risk
How to calculate the maximum risk— reply
Resistance to activated protein C is reduced in women using oral contraceptives
Hemostasis and Thrombosis: Basic Principles and Clinical Practice
DIC Pathogenesis Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation